• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>TomoTherapy

TomoTherapy

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Global Radiotherapy Market by Products (Proton Therapy, Linear Accelerator, CyberKnife, Gamma Knife and TomoTherapy ) Market Outlook 2022 - Research and Markets

    Global Radiotherapy Market by Products (Proton Therapy, Linear Accelerator, CyberKnife, Gamma Knife and TomoTherapy ) Market Outlook 2022 - Research and Markets

  2. MicroVision to Showcase the Capabilities of its New Display and 3D Sensing Engines at CES 2017

    MicroVision to Showcase the Capabilities of its New Display and 3D Sensing Engines at CES 2017

  3. Radiation Oncology Market, 2021 - Research and Markets

    Radiation Oncology Market, 2021 - Research and Markets

  4. MicroVision Raises $2.14 Million From the Sale of Common Stock

    MicroVision Raises $2.14 Million From the Sale of Common Stock

  5. Tax Reform: Camp Fires Up the Debate

    TOM Online TOMO suspended trading on March 5 in anticipation of a potential privatization by the firm's parent company--TOM Group Limited, which currently owns about 65.7% of the firm's share capital. We're placing TOM Online under review while we wait for further information about the deal. The ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.